A new survey, carried out by UK-based mental health charity Rethink and the European Federation of Associations of Families of People with Mental Illness (EUFAMI), was published at the last day of the Commission's consultation on the green paper on mental health.
The study, funded by the pharmaceutical company AstraZeneca, has collected views of citizens with mental ill health, their careers and families on what the EU should take into account when formulating its strategy for mental health.
The survey results highlight the problem of social exclusion and discrimination and stigma surrounding mental illness, which condemn people with mental illness to isolation. Therefore, 95% of the respondents would want to see greater public understanding of mental health. People with mental health problems are also less likely to find employment, although 63% state they would like to work.
Huge majority of the respondents (90%) also calls for access to medication with less adverse side effects, highlighting this as the best way to improve their quality of life. Adverse side effects include weight gain, sweating and sexual dysfunction.



